Clinical Trial Update: Use of Oxandrolone to Promote Growth in Infants With HLHS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating oxandrolone to promote growth in infants with Hypoplastic Left Heart Syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Hypoplastic Left Heart Syndrome

Drugs mentioned

• Oxandrolone (Oxandrolone)

Snippet

Sponsor: Carelon Research | Conditions: Hypoplastic Left Heart, Congenital Heart Disease | Phase 1, Phase 2 | Status: TERMINATED